SC 13G Filing

Company

Crinetics Pharmaceuticals, Inc.

Filed

October 29, 2021

Accession Number

0000921895-21-002496

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →